The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease
- 1 April 2000
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , 795-798
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosaGastroenterology, 2000
- Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazoleGastroenterology, 1999
- The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapyAlimentary Pharmacology & Therapeutics, 1999
- Helicobacter pylori and the Efficacy of Omeprazole Therapy for Gastroesophageal Reflux DiseaseAmerican Journal of Gastroenterology, 1999
- Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjectsGastroenterology, 1998
- Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole.Alimentary Pharmacology & Therapeutics, 1997
- Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and SafetyAnnals of Internal Medicine, 1994
- Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritisGastroenterology, 1993
- Long-term maintenance treatment of reflux esophagitis with omeprazoleDigestive Diseases and Sciences, 1991
- Combined gastric and oesophageal 24‐hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole.Alimentary Pharmacology & Therapeutics, 1990